Zobrazeno 1 - 10
of 616
pro vyhledávání: ''
Autor:
Anna Wall, Herve Ghesquieres, Viola Poeschel, Jesse G. Dixon, Hervé Tilly, Marita Ziepert, Amy S. Ruppert, Qian Shi, David Cunningham, Norbert Schmitz, Christopher R. Flowers, Corinne Haioun, Jocelyne Flament, Gilles Salles
Great heterogeneity in survival exists for patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL). Three scoring systems incorporating simple clinical parameters (age, lactate dehydrogenase, number/sites of involvement, stage, performanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86b84f2887e4b5caa58b54159bae05ed
Autor:
Julio C. Chavez, James Drew, John P. Leonard, Erin Mulvey, Sonali M. Smith, Leandro Cerchietti, Nancy L. Bartlett, John L. Reagan, Jeffrey A. Jones, Ann S. LaCasce, Peter Martin, Maria Victoria Revuelta, Chengqing Wu
Publikováno v:
Blood. 139:1147-1159
Resistance to standard immunochemotherapy remains an unmet challenge in diffuse large B-cell lymphoma (DLBCL), and aberrant DNA methylation may contribute to chemoresistance. Promising early-phase results were reported with rituximab, cyclophosphamid
Autor:
Panpan Han, Jun Peng, Guosheng Li, Yu Hou, Yang Liu, Haoyi Wang, Yunqi Sun, Tianshu Yu, Hai Zhou, Ming Hou, Xinguang Liu, Lizhen Li, Yajing Zhao, Pengcheng Xu, Xiang Hu, Tao Sun
Publikováno v:
Blood. 138:674-688
Our previous clinical study showed that low-dose decitabine exhibited sustained responses in nearly half of patients with refractory immune thrombocytopenia (ITP). The long-term efficacy of decitabine in ITP is not likely due to its simple role in in
Autor:
Adrienne A. Phillips, Lucy Cook
Publikováno v:
Blood. 137:459-470
Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive T-cell malignancy that arises in a proportion of individuals who are long-term carriers of human T-lymphotropic virus type 1. The median survival of aggressive subtypes is 8 to 10 months; wi
Autor:
Jaclyn Garza Grenier, R. Coleman Lindsley, Corey Cutler, Wael Saber, Mikko Myllymäki, Zhen-Huan Hu, Donna Neuberg, Christopher R. Reilly, Stephen R. Spellman, Esther H. Orr, Immaculata De Vivo, Joseph H. Antin, Tao Wang, Christopher J. Gibson, Maxine M. Chen, David P. Steensma, Robert A. Redd, Suneet Agarwal
Publikováno v:
Blood
Allogeneic hematopoietic stem cell transplantation is the only potentially curative treatment for patients with myelodysplastic syndrome (MDS), but long-term survival is limited by the risk of transplant-related complications. Short telomere length,
Autor:
Ping-Chiao Tsai, Zuguang Xia, Kai Xue, Fangfang Lv, Francisco J. Hernandez-Ilizaliturri, Junning Cao, Xiaojian Liu, Ye Guo, Cory Mavis, Yizhen Liu, Qunling Zhang, Xiaonan Hong, Juan J Gu, Ling Yang
Publikováno v:
Aging (Albany NY)
Intercellular adhesion molecule-1 (ICAM-1) is a cell-surface receptor contributing to lymphocyte homing, adhesion and activation. The prognostic significance of the protein is unknown in diffuse large B-cell lymphoma (DLBCL) in post-rituximab era. We
Autor:
Xixi Chen, Beibei Yang, Jiang-Tao Li, Yuchen Jiao, Linqian Weng, Jin Ye, Weilong Zhang, Hongmei Jing, Hui Liu, Ting Wang, Yi Xin Zeng, Jingwen Wang, Jiefei Bai
Publikováno v:
Aging (Albany NY)
The treatment of chronic myeloid leukemia (CML), a disease caused by t(9;22)(q34;q11) reciprocal translocation, has advanced largely through the use of targeted tyrosine kinase inhibitors (TKIs). To identify molecular differences that might distingui
Autor:
Satoshi Yamashita, Naoko Hattori, Yuki Kurahashi, Toshikazu Ushijima, Naoko Sueoka-Aragane, Tatsuro Watanabe, Akemi Sato, Kensuke Kojima, Hideaki Nakamura, Atsushi Kawaguchi, Shinya Kimura, Eisaburo Sueoka, Nao Yoshida, Kazuharu Kamachi, Seiji Okada, Hiroshi Ureshino, Yuki Fukuda-Kurahashi
Publikováno v:
Blood. 136:871-884
Adult T-cell leukemia-lymphoma (ATL) is an aggressive hematological malignancy of CD4+ T cells transformed by human T-cell lymphotropic virus-1 (HTLV-1). Most HTLV-1–infected individuals are asymptomatic, and only 3% to 5% of carriers develop ATL.
Autor:
Julie Abraham, Marc Simon, Hervé Tilly, Josette Brière, Anne-Ségolène Cottereau, Lucie Oberic, Michel Meignan, Olivier Casasnovas, Olivier Fitoussi, Pascal Godmer, Christophe Fruchart, Laurence Sanhes, Laetitia Vercellino, Gian Matteo Pica, Pierre Feugier, Gilles Salles, Vincent Ribrag, Catherine Thieblemont, Armando López-Guillermo, Judith Trotman, Bernadette Corront, Loïc Chartier, Hugo Gonzalez, Franck Morschhauser, Philippe Gaulard, Bachra Choufi, Catherine Sebban, L. Roulin, Reda Bouabdallah, Sylvia Snauwaert
Publikováno v:
Blood. 135:1396-1405
Early identification of ultra-risk diffuse large B-cell lymphoma (DLBCL) patients is needed to aid stratification to innovative treatment. Previous studies suggested high baseline total metabolic tumor volume (TMTV) negatively impacts survival of DLB
Autor:
Julianne Chen, Qaiser Bashir, Samer A. Srour, Richard E. Champlin, Rohtesh S. Mehta, Betul Oran, Gabriela Rondon, Uday R. Popat, Ankur Varma, Stefan O. Ciurea, Amin M. Alousi, Piyanuch Kongtim, Naval Daver, Chitra Hosing, Amanda Olson, Marina Konopleva
Publikováno v:
Blood
The optimal conditioning regimen for older patients with acute myeloid leukemia (AML) remains unclear. In this study, we compared outcomes of AML patients >60 years of age undergoing allogenic hematopoietic stem cell transplantation at our institutio